Literature DB >> 16802031

HPLC analysis of functionalized poly(amidoamine) dendrimers and the interaction between a folate-dendrimer conjugate and folate binding protein.

Xiangyang Shi1, Xiangdong Bi, T Rose Ganser, Seungpyo Hong, Lukasz A Myc, Ankur Desai, Mark M Banaszak Holl, James R Baker.   

Abstract

Poly(amidoamine) (PAMAM) dendrimers of different generations with carboxyl, acetyl, and hydroxyl terminal groups and a folic acid (FA)-dendrimer conjugate were separated and analyzed using reverse-phase high performance liquid chromatography (HPLC). Analysis of both the individual PAMAM derivatives and the separation of mixed generations can be achieved using a linear gradient 0-50% acetonitrile (ACN) (balance water) within 40 min. We also show that PAMAMs with defined acetylation and carboxylation degrees can be analyzed using HPLC. Furthermore, a generation 5 dendrimer-FA conjugate (G5.75Ac-FA4; Ac denotes acetyl) was analyzed and its specific binding with a bovine folic acid binding protein (FBP) was monitored. The HPLC and sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) results indicate the formation of three complexes after the binding of G5.75Ac-FA4 with FBP. Dendrimers with FA moieties show much higher specific binding capability with FBP than those without FA moieties. Findings from this study indicate that HPLC is an effective technique not only for characterization and separation of functionalized PAMAM dendrimers and conjugates but also for investigation of the interaction between dendrimers and biomolecules.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16802031     DOI: 10.1039/b602546c

Source DB:  PubMed          Journal:  Analyst        ISSN: 0003-2654            Impact factor:   4.616


  9 in total

1.  Quantitative analysis of generation and branch defects in G5 poly(amidoamine) dendrimer.

Authors:  Mallory A van Dongen; Ankur Desai; Bradford G Orr; James R Baker; Mark M Banaszak Holl
Journal:  Polymer (Guildf)       Date:  2013-07-19       Impact factor: 4.430

2.  A quantitative assessment of nanoparticle-ligand distributions: implications for targeted drug and imaging delivery in dendrimer conjugates.

Authors:  Douglas G Mullen; Ming Fang; Ankur Desai; James R Baker; Bradford G Orr; Mark M Banaszak Holl
Journal:  ACS Nano       Date:  2010-02-23       Impact factor: 15.881

3.  Targeted dendrimeric anticancer prodrug: a methotrexate-folic acid-poly(amidoamine) conjugate and a novel, rapid, "one pot" synthetic approach.

Authors:  Yuehua Zhang; Thommey P Thomas; Ankur Desai; Hong Zong; Pascale R Leroueil; Istvan J Majoros; James R Baker
Journal:  Bioconjug Chem       Date:  2010-02-03       Impact factor: 4.774

4.  The implications of stochastic synthesis for the conjugation of functional groups to nanoparticles.

Authors:  Douglas G Mullen; Ankur M Desai; Jack N Waddell; Xue-Min Cheng; Christopher V Kelly; Daniel Q McNerny; István J Majoros; James R Baker; Leonard M Sander; Bradford G Orr; Mark M Banaszak Holl
Journal:  Bioconjug Chem       Date:  2008-08-26       Impact factor: 4.774

5.  Best practices for purification and characterization of PAMAM dendrimer.

Authors:  Douglas G Mullen; Ankur Desai; Mallory A van Dongen; Mark Barash; James R Baker; Mark M Banaszak Holl
Journal:  Macromolecules       Date:  2012-06-11       Impact factor: 5.985

6.  Low-Level Detection of Poly(amidoamine) PAMAM Dendrimers Using Immunoimaging Scanning Probe Microscopy.

Authors:  Chevelle A Cason; Thomas A Fabré; Andrew Buhrlage; Kristi L Haik; Heather A Bullen
Journal:  Int J Anal Chem       Date:  2012-02-08       Impact factor: 1.885

7.  Diffusion NMR study of generation-five PAMAM dendrimer materials.

Authors:  Mallory A van Dongen; Bradford G Orr; Mark M Banaszak Holl
Journal:  J Phys Chem B       Date:  2014-06-13       Impact factor: 2.991

Review 8.  Nanoapproaches to Modifying Epigenetics of Epithelial Mesenchymal Transition for Treatment of Pulmonary Fibrosis.

Authors:  Melissa Skibba; Adam Drelich; Michael Poellmann; Seungpyo Hong; Allan R Brasier
Journal:  Front Pharmacol       Date:  2020-12-11       Impact factor: 5.810

9.  Dendrimer-based posaconazole nanoplatform for antifungal therapy.

Authors:  Shengzhuang Tang; Jesse Chen; Jayme Cannon; Zhengyi Cao; James R Baker; Su He Wang
Journal:  Drug Deliv       Date:  2021-12       Impact factor: 6.419

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.